Nerual
Nerual has been active since 2013 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €19k and a net result of €83k. Equity is shrinking by ~3% per year across the filed fiscal years. Its solvency ranks better than 24% of 4760 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
| Equity | €19k |
| Net result | €83k |
| Better than sector | 24% |
| Active | 13 yrs |
Strong profile, led by profitability.
All 5 axes are computed from data Checked has read.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 18.0% | 55.4% | |
| Net result | €83k | €38k | |
| Equity | €19k | €64k | |
| Gross operating margin | €127k | €61k | |
| Total assets | €103k | €146k |
Figures by fiscal year and ratios
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Deposit | micro schema | micro schema | micro schema | micro schema |
| Revenue | - | - | - | - |
| EBITDA | €127k | €133k | €144k | €136k |
| Net profit | €83k | €89k | €103k | €96k |
| Cash flow | €103k | €106k | €115k | €108k |
| Staff costs | - | - | - | - |
| Income taxes | €23k | €24k | €29k | €27k |
| Dividends | €85k | €90k | €102k | €97k |
| Total assets | €103k | €178k | €168k | €172k |
| Equity | €19k | €20k | €21k | €21k |
| Debt | €84k | €157k | €147k | €151k |
| of which ≤ 1y | €44k | €105k | €113k | €113k |
| of which > 1y | €41k | €52k | €34k | €39k |
| Working capital | €19k | €16k | €19k | €15k |
| Employees (FTE) | - | - | - | - |
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Current ratio | 1.43 | 1.15 | 1.17 | 1.13 |
| Quick ratio | 1.43 | 1.15 | 1.17 | 1.13 |
| Working capital ratio | 18.3% | 9.1% | 11.3% | 8.8% |
| Solvency | 18.0% | 11.5% | 12.5% | 11.9% |
| Debt / equity | 4.54 | 7.69 | 6.98 | 7.38 |
| Long-term debt ratio | 2.18 | 2.56 | 1.60 | 1.88 |
| Interest coverage | 59.38 | 54.33 | 184.13 | 145.32 |
| Gross margin | - | - | - | - |
| Net margin | - | - | - | - |
| ROA | 80.3% | 50.1% | 61.0% | 56.1% |
| ROE | 444.9% | 435.2% | 486.9% | 470.2% |
| EBITDA margin | - | - | - | - |
| Days sales outstanding | - | - | - | - |
| Days payable outstanding | - | - | - | - |
| Inventory turnover | - | - | - | - |
| Days inventory (DSI) | - | - | - | - |
Full annual accounts (23 line items)
| Line item | Code | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Balance sheet, Assets | |||||
| TOTAL ASSETS | 20/58 | €103k | €178k | €168k | €172k |
| Fixed assets | 21/28 | €40k | €57k | €36k | €44k |
| Tangible fixed assets | 22/27 | €40k | €57k | €36k | €44k |
| Current assets | 29/58 | €63k | €121k | €132k | €128k |
| Amounts receivable within one year | 40/41 | €45k | €34k | €40k | €18k |
| Cash & bank | 54/58 | €17k | €84k | €84k | €109k |
| Balance sheet, Equity & liabilities | |||||
| TOTAL EQUITY & LIABILITIES | 10/49 | €103k | €178k | €168k | €172k |
| Equity | 10/15 | €19k | €20k | €21k | €21k |
| Contributions / capital | 10/11 | €19k | €19k | €19k | €19k |
| Reserves | 13 | €0 | €2k | €2k | €2k |
| Accumulated profits (losses) | 14 | - | - | €602 | €49 |
| Amounts payable | 17/49 | €84k | €157k | €147k | €151k |
| Amounts payable after one year | 17 | €41k | €52k | €34k | €39k |
| Amounts payable within one year | 42/48 | €44k | €105k | €113k | €113k |
| Trade debts payable within one year | 44 | €1k | €761 | €1k | €3k |
| Income statement | |||||
| Gross operating margin | 9900 | €127k | €133k | €144k | €137k |
| Operating result | 9901 | €107k | €116k | €132k | €125k |
| Financial income | 75 | €210 | €285 | €86 | €2 |
| Financial charges | 65 | €2k | €2k | €782 | €935 |
| Result before taxes | 9903 | €105k | €113k | €131k | €124k |
| Income taxes | 67/77 | €23k | €24k | €29k | €27k |
| Net result for the period | 9904 | €83k | €89k | €103k | €96k |
| Result to be appropriated | 9905 | €83k | €89k | €103k | €96k |
| NACE primary | Business and other management consultancy(70200) |
| Legal form | Private limited company(610) |
| Incorporation | 09-07-2013 |
| Status | Active |
| Postal code | 2160 |
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11052D0189/00S000 | Flanders | 960 m² | 1 · 147 m² | 0.0 m |
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
| Legal nameNL | Nerual |